子宫内膜消融或切除与左炔诺孕酮宫内系统治疗月经过多的系统评价与荟萃分析
该系统评价纳入13项随机对照试验(N=884),比较子宫内膜消融/切除与LNG-IUS治疗月经过多且宫腔正常女性的疗效与安全性。两组子宫切除率、满意度、生活质量、闭经及治疗失败无显著差异,但消融/切除组副作用更少;年轻女性(平均年龄≤42岁)中LNG-IUS的子宫切除风险更低。
要点
- 消融/切除与LNG-IUS在子宫切除率、满意度、生活质量、闭经及治疗失败方面无显著差异。
- 消融/切除组副作用发生率显著低于LNG-IUS组(RR=0.52)。
- 平均年龄≤42岁女性中,消融/切除组后续子宫切除风险高于LNG-IUS组(RR=5.26)。
核心结论
- 子宫内膜消融/切除与LNG-IUS均为月经过多的一线治疗选择,疗效与安全性总体相当,但副作用谱和不同年龄段的子宫切除风险存在差异。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、EMBASE、CENTRAL、Web of Science、Biosis及Google Scholar等数据库至2019年8月,纳入13项随机对照试验(N=884),比较子宫内膜消融/切除与LNG-IUS治疗月经过多且宫腔正常的绝经前女性。
主要发现
- 主要结局后续子宫切除率两组无显著差异(RR=1.13,95%CI 0.60-2.11,P=0.71,I2=14%,12项研究,726名女性)。
- 满意度、生活质量、闭经及治疗失败两组均无显著差异。
- 副作用在消融/切除组更少见(RR=0.52,95%CI 0.37-0.71,P<0.001,I2=0%,10项研究,580名女性)。
- 消融/切除组报告3例并发症,LNG-IUS组无并发症(P=0.25)。
- 平均年龄是异质性来源(P=0.01):平均年龄≤42岁人群中,消融/切除组后续子宫切除风险更高(RR=5.26,95%CI 1.21-22.91,P=0.03,I2=0%,3项研究,189名女性);平均年龄>42岁人群中,消融/切除组子宫切除风险似较低但无统计学意义(RR=0.51,95%CI 0.21-1.24,P=0.14,I2=0%,5项研究,297名女性)。
临床怎么用
- 选择治疗方案时应结合患者年龄、副作用耐受性和生育愿望个体化决策;年轻女性使用LNG-IUS可能降低远期子宫切除风险,而消融/切除副作用更少。
局限性
- 多数研究仅报告至3年结局,两种治疗方案的长期相对效果未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometrial ablation/resection and the levonorgestrel intra-uterine system (LNG-IUS) are well-established treatment options for heavy menstrual bleeding to avoid more invasive alternatives, such as hysterectomy. OBJECTIVE: The aim was to compare the efficacy and safety of endometrial ablation or resection with the LNG-IUS in the treatment of premenopausal women with heavy menstrual bleeding and to investigate sources of heterogeneity between studies. SEARCH METHODS: We searched the databases MEDLINE, EMBASE, CENTRAL, Web of Science, Biosis and Google Scholar as well as citations and reference lists published up to August 2019. Two authors independently screened 3701 citations for eligibility. We included randomized controlled trials published in any language, comparing endometrial ablation or resection to the LNG-IUS in the treatment of premenopausal women with heavy menstrual bleeding and a normal uterine cavity. OUTCOMES: Thirteen studies (N = 884) were eligible. Two independent authors extracted data and assessed the quality of included studies. Random effect models were used to compare the modalities and evaluate sources of heterogeneity. No significant differences were observed between endometrial ablation/resection and the LNG-IUS in terms of subsequent hysterectomy (primary outcome, risk ratio (RR) = 1.13, 95% CI 0.60 to 2.11, P = 0.71, I2 = 14%, 12 studies, 726 women), satisfaction, quality of life, amenorrhea and treatment failure. However, side effects were less common in women treated with endometrial ablation/resection compared to the LNG-IUS (RR = 0.52, 95% CI 0.37 to 0.71, P < 0.001, I2 = 0%, 10 studies, 580 women). Three complications were reported in the endometrial ablation/resection group and none in the LNG-IUS group (P = 0.25). Mean age of the studied populations was identified as a significant source of heterogeneity between studies in subgroup analysis (P = 0.01). In fact, endometrial ablation/resection was associated with a higher risk of subsequent hysterectomy compared to the LNG-IUS in younger populations (mean age ≤ 42 years old, RR = 5.26, 95% CI 1.21 to 22.91, P = 0.03, I2 = 0%, 3 studies, 189 women). On the contrary, subsequent hysterectomy seemed to be less likely with endometrial ablation/resection compared to the LNG-IUS in older populations (mean age > 42 years old), although the reduction did not reach statistical significance (RR = 0.51, 95% CI 0.21 to 1.24, P = 0.14, I2 = 0%, 5 studies, 297 women). Finally, sensitivity analysis taking into account the risk of bias of included studies and type of surgical devices (first and second generation) did not modify the results. Most of the included studies reported outcomes at up to 3 years, and the relative performance of endometrial ablation/resection and LNG-IUS remains unknown in the longer term. WIDER IMPLICATIONS: Endometrial ablation/resection and the LNG-IUS are two excellent treatment options for heavy menstrual bleeding, although women treated with the LNG-IUS are at higher risk of experiencing side effects compared to endometrial ablation/resection. Otherwise, younger women seem to present a lower risk of eventually requiring hysterectomy when treated with the LNG-IUS compared to endometrial ablation/resection.
引用
- Bergeron C, Laberge PY, Boutin A, et al. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis. Hum Reprod Update. 2020. PMID: 31990359. doi:10.1093/humupd/dmz051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。